Osler, Hoskin & Harcourt LLP advised SK On on the matter. SK On, EcoPro BM, and Ford announced an investment of $1.2 billion to build a...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt LLP advised Nichi-Iko Pharmaceutical Co. on the sale. Nichi-Iko Pharmaceutical Co., Ltd. sold all issued and outstanding shares of its wholly owned...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt LLP advised BoostSecurity on the financing. On November 16, 2022, BoostSecurity announced it had secured $12 million in seed funding led by...
You must be a Standard 1 Year member to access this content.
White & Case and Osler, Hoskin & Harcourt LLP advised Inversago Pharma Inc. on the deal, while Wilson Sonsini advised NEA. Inversago Pharma Inc., a clinical-stage...
You must be a Standard 1 Year member to access this content.
Osler, Hoskin & Harcourt LLP advised Parity Inc. on the matter. On October 11, 2022, Parity Inc. announced it had closed $8 million in financing, strengthening...
You must be a Standard 1 Year member to access this content.
